Why is Rossari Biotech falling/rising?

As of 17-Jul, Rossari Biotech Ltd is experiencing a price increase, currently at Rs 739.00, reflecting a rise of 6.65 (0.91%). The stock has shown a positive performance today, outperforming its sector by 0.66% and opening with a gain of 2.4%. It reached an intraday high of Rs 749.95. Over the past week, the stock has increased by 5.44%, while its one-month return stands at 9.20%. Despite a year-to-date decline of 6.18%, the company has demonstrated a low Debt to Equity ratio and an attractive valuation with a Price to Book Value of 3.5. Additionally, the stock is trading at a discount compared to its peers, and its profits have risen by 4.4% over the past year, contributing to a more favorable outlook. In the broader market context, the Sensex has declined by 1.12% over the past week, contrasting with Rossari Biotech's positive short-term return. This indicates that the stock is performing well against the benchmark. However, it is important to note that there has been a decrease in investor participation, with delivery volume falling by 13.53% against the five-day average. Despite this, the stock remains liquid enough for trading, supported by high institutional holdings at 21.32%, which may provide stability and confidence in the company's fundamentals.